A combined approach to treating metastatic melanoma
from Medical News Today
Oncologists at the Fred Hutchinson Cancer Research Center have successfully treated a patient with metastatic melanoma by combining two different types of immunotherapy. Cassian Yee and colleagues describe their approach in a paper, "Combined IL-21-primed polyclonal CTL plus CTLA4 blockade controls refractory metastatic melanoma in a patient," published online in The Journal of Experimental Medicine.
7701 Las Colinas Blvd., Ste. 800, Irving, TX 75063